Novartis Ag (NVS) Amortization - Intangibles (2009 - 2014)
Novartis Ag (NVS) posted Amortization - Intangibles of $164.0 for Q1 2010, down 70.82% sequentially from $562.0 in Q4 2009.
Novartis Ag (NVS) Amortization - Intangibles (2009 - 2014) Analysis & Trends
Novartis Ag (NVS) has 2 years of Amortization - Intangibles data on file, last reported at $164.0 in Q1 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -2,852.00 |
| Dec 31, 2013 | -2,976.00 |
| Mar 31, 2012 | 714.00 |
| Mar 31, 2011 | 781.00 |
| Dec 31, 2010 | -1.14 Bn |
| Mar 31, 2010 | 164.00 |
| Dec 31, 2009 | -1.03 Bn |